186 related articles for article (PubMed ID: 38663316)
1. Cope with copper: From molecular mechanisms of cuproptosis to copper-related kidney diseases.
Zou Y; Wu S; Xu X; Tan X; Yang S; Chen T; Zhang J; Li S; Li W; Wang F
Int Immunopharmacol; 2024 May; 133():112075. PubMed ID: 38663316
[TBL] [Abstract][Full Text] [Related]
2. The molecular mechanisms of cuproptosis and its relevance to cardiovascular disease.
Wang D; Tian Z; Zhang P; Zhen L; Meng Q; Sun B; Xu X; Jia T; Li S
Biomed Pharmacother; 2023 Jul; 163():114830. PubMed ID: 37150036
[TBL] [Abstract][Full Text] [Related]
3. Copper homeostasis and cuproptosis in health and disease.
Chen L; Min J; Wang F
Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
[TBL] [Abstract][Full Text] [Related]
4. Cuproptosis: potential new direction in diabetes research and treatment.
Qu J; Wang Y; Wang Q
Front Endocrinol (Lausanne); 2024; 15():1344729. PubMed ID: 38904034
[TBL] [Abstract][Full Text] [Related]
5. ATF3/SPI1/SLC31A1 Signaling Promotes Cuproptosis Induced by Advanced Glycosylation End Products in Diabetic Myocardial Injury.
Huo S; Wang Q; Shi W; Peng L; Jiang Y; Zhu M; Guo J; Peng D; Wang M; Men L; Huang B; Lv J; Lin L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675183
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
[TBL] [Abstract][Full Text] [Related]
7. Cuproptosis is involved in copper-induced hepatotoxicity in chickens.
Zhong G; Li L; Li Y; Ma F; Liao J; Li Y; Zhang H; Pan J; Hu L; Tang Z
Sci Total Environ; 2023 Mar; 866():161458. PubMed ID: 36621474
[TBL] [Abstract][Full Text] [Related]
8. Copper's dual role: unravelling the link between copper homeostasis, cuproptosis, and cardiovascular diseases.
Parsanathan R
Hypertens Res; 2024 May; 47(5):1440-1442. PubMed ID: 38467792
[TBL] [Abstract][Full Text] [Related]
9. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
10. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
Feng Y; Yang Z; Wang J; Zhao H
Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of cuproptosis and its relevance to distinct diseases.
Lou QM; Lai FF; Li JW; Mao KJ; Wan HT; He Y
Apoptosis; 2024 Jun; ():. PubMed ID: 38824478
[TBL] [Abstract][Full Text] [Related]
12. Interplay of Ferroptosis and Cuproptosis in Cancer: Dissecting Metal-Driven Mechanisms for Therapeutic Potentials.
Wang J; Li J; Liu J; Chan KY; Lee HS; Lin KN; Wang CC; Lau TS
Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339263
[TBL] [Abstract][Full Text] [Related]
13. Research progress in cuproptosis in liver cancer.
Chen L; Liu D; Tan Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1368-1376. PubMed ID: 38044648
[TBL] [Abstract][Full Text] [Related]
14. Copper homeostasis and cuproptosis in mitochondria.
Tian Z; Jiang S; Zhou J; Zhang W
Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
[TBL] [Abstract][Full Text] [Related]
15. Cuproptosis: Mechanism, role, and advances in urological malignancies.
Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
[TBL] [Abstract][Full Text] [Related]
16. SP1/CTR1-mediated oxidative stress-induced cuproptosis in intervertebral disc degeneration.
Chen X; Li K; Xiao Y; Wu W; Lin H; Qing X; Tian S; Liu S; Feng S; Wang B; Shao Z; Peng Y
Biofactors; 2024 Apr; ():. PubMed ID: 38599595
[TBL] [Abstract][Full Text] [Related]
17. Environmental copper exposure, placental cuproptosis, and miscarriage.
Zhao J; Xu Z; Wang X; Wan S; Chen W; Huang W; Wang M; Wang R; Zhang H
Environ Pollut; 2024 May; 348():123847. PubMed ID: 38552771
[TBL] [Abstract][Full Text] [Related]
18. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
19. Elesclomol, a copper-transporting therapeutic agent targeting mitochondria: from discovery to its novel applications.
Tarin M; Babaie M; Eshghi H; Matin MM; Saljooghi AS
J Transl Med; 2023 Oct; 21(1):745. PubMed ID: 37864163
[TBL] [Abstract][Full Text] [Related]
20. The Cross-Communication of Cuproptosis and Regulated Cell Death in Human Pathophysiology.
Tsui KH; Hsiao JH; Lin LT; Tsang YL; Shao AN; Kuo CH; Chang R; Wen ZH; Li CJ
Int J Biol Sci; 2024; 20(1):218-230. PubMed ID: 38164173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
